PDB15 COMPARATIVE COST-UTILITY ANALYSIS OF LONG-ACTING INSULIN ANALOGUE (INSULIN DETEMIR) AND NPH INSULIN FOR THE TREATMENT OF TYPE 1 AND TYPE 2 DIABETES AND THE BUDGET IMPACT ANALYSIS OF INSULIN ANALOGUE REIMBURSEMENT IN POLAND
Abstract
Authors
J Walczak D Pawlik A Jasinska M Garbacka J Kedzior T Fundament I Malczak W Dardzinski I Skrzekowska-Baran M Czech G Nogas